Application · Mass Spectrometry Imaging

Spatial Proteomics: Localizing Proteins in Tissue Space

Proteins are the direct executors of function, but their expression and post-translational modifications show marked spatial heterogeneity. Spatial proteomics uses mass spectrometry imaging (MSI) and related techniques to reveal the in-situ spatial distribution of proteins, peptides, and their modifications across tissue structures, allowing researchers to see where proteins localize in tissue—without 'homogenization'.
Table of Contents
1. What Spatial Proteomics Addresses2. The Role of MSI in Protein Imaging3. Workflow and Validation4. Interpretation Boundaries and Multi-Omics Integration
Schematic principle: ion source ionizes the sample spot-by-spot Tissue section Sample Ionization beam Spatial Proteomics: Localizing Proteins in Tissue Space Ions MS analyzer
Spatial Proteomics: Localizing Proteins in Tissue Space — schematic diagram

1. What Spatial Proteomics Addresses

Many biological questions are essentially spatial: why is a certain protein highly expressed only in the tumor region? Why does the modification state differ at the marginal band? Traditional proteomics homogenizes to measure average amounts, flattening these differences. Spatial proteomics uses MSI or spatial proteomics workflows to preserve structure, directly presenting the spatial heterogeneity of proteins/peptides.

In the Neo-Source product system, the MSI imaging sources (DPI, LDPI) provide in-situ acquisition capability of 'molecule–coordinate'; protein imaging can convert protein information into imageable peptide or ion signals via the appropriate sample preparation (e.g., enzymatic digestion, or matrix-assisted / matrix-free routes).

2. The Role of MSI in Protein Imaging

MSI can present in-situ the spatial distribution of polypeptides, protein-related ions and modification features; the Neo-Source MSI DPI is matrix-free, has low ion suppression and direct analysis of complex samples, with 20–200 μm adjustable resolution, suited to research that requires localizing protein-related signals within tissue.

Higher spatial-resolution needs (e.g., whether proteins localize to a certain cell band or subcellular structure) can be supplemented by the 2–3 μm matrix-free ambient imaging of the Neo-Source MSI LDPI, covering different scales from organ to single-cell/subcellular.

3. Workflow and Validation

Protein imaging often requires preparation such as enzymatic digestion to convert proteins into measurable ions, combined with matrix or matrix-free routes. Results must be registered against validation methods such as immunofluorescence, IHC, and Western blot to confirm that the signal coincides with the expected histological structure. The two Neo-Source imaging sources keep the section intact after imaging for continued H&E or IHC validation.

The engineering value of matrix-free preparation is highlighted here: DPI and LDPI are matrix-free and measure on demand, reducing sample handling from 'at best half a day' down to on-demand measurement, significantly accelerating protein spatial research that requires many sample comparisons.

4. Interpretation Boundaries and Multi-Omics Integration

Protein MSI still faces challenges such as complex preparation, ionization-efficiency differences and quantitative calibration; conclusions should be cross-validated with complementary methods such as immunology, transcriptomics and metabolomics. Spatial proteomics is often combined with spatial metabolomics and spatial lipidomics to form multi-omics integrated imaging.

Engineered, the two Neo-Source imaging sources are compatible with mainstream mass spectrometers from Agilent, AB SCIEX and Thermo, providing a proprietary titanium-alloy ion-transfer tube that does not damage the sample at the front end and is detachable for cleaning, supporting stable and reproducible spatial proteomics research.

Frequently Asked Questions (FAQ)

What is the difference between spatial proteomics and ordinary proteomics?
Ordinary proteomics homogenizes the sample to measure average abundance, losing spatial information; spatial proteomics uses MSI and related methods to reveal the in-situ spatial distribution of proteins and peptides while preserving tissue structure.
Can MSI directly image intact proteins?
Proteins usually require preparation such as enzymatic digestion to convert them into measurable ion or peptide signals; MSI then acquires their in-situ spatial distribution, often registered against immunological validation.
Why does protein imaging require high resolution?
High resolution makes it possible to determine whether proteins localize to specific cell layers or subcellular structures; the 2–3 μm LDPI can reach the single-cell and subcellular scale.
Can spatial proteomics draw conclusions on its own?
It is recommended to cross-validate with complementary methods such as immunofluorescence, IHC, transcriptomics, and metabolomics; MSI mainly provides evidence in the protein spatial dimension.

Get Specifications & Quotation

To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).

Related Articles

DPI Dual-Photoionization Imaging SourceNeo-Source MSI LDPI Laser Desorption Photoionization imaging ion sourceProtein Imaging: Nailing Proteins into Tissue SpaceMulti-Omics Integrated Imaging: Assembling Multiple Molecular Spatial Maps into a PanoramaSpatial Metabolomics MSI: Bringing Metabolomics into Real Tissue Space

← Back to MSI Ion Source Knowledge Hub